Mohamed Nagy

Sep 16, 2024 | insights.omnia-health.com | Mohamed Nagy

Personalised medicine, the tailoring of medical treatment to each patient's individual characteristics, is revolutionising healthcare. At the heart of this transformation lies therapeutic drug monitoring (TDM), which measures drug concentrations in patients' blood to optimise therapy and minimise adverse effects. The clinical pharmacist or pharmacologist plays a pivotal role in the TDM laboratory, architecting personalised medication strategies.

Aug 6, 2024 | insights.omnia-health.com | Mohamed Nagy

The era of generic prescriptions and standardised treatment plans is rapidly giving way to a new paradigm in healthcare: personalised medication management. This innovative approach recognises the inherent individuality of each patient, acknowledging that factors like genetic makeup, lifestyle choices, concurrent medications, and underlying health conditions can profoundly influence how a person responds to a particular drug.

May 16, 2024 | futuremedicine.com | Mohamed Kamal |Mohamed Nagy |Omneya Hassanain

The application of personalized medicine in developing countries is a major challenge, especially for those with poor economic status. A critical factor in improving the application of personalized medicine is the efficient allocation of resources. In healthcare systems, optimizing resource allocation without compromising patient care is paramount. This tutorial employs a simulation-based approach to evaluate the efficiency of bed allocation within a hospital setting.

Feb 6, 2024 | insights.omnia-health.com | Mohamed Nagy

![CDATA[//><!]]>--><![CDATA[//><!]]>--><![CDATA[//><!]]>--> Subscribe Log In HomeLaboratoryPharmacogenomics in oncology: advancing personalised cancer treatmentRecent Pharmacogenomics has the potential to revolutionise cancer treatment by enabling effective treatment tailored to an individual patient's unique genetic makeup. Pharmacogenomics (PGx) studies how an individual's genetic makeup affects their drug response.